Ignite Creation Date:
2024-05-06 @ 7:17 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02508467
Status:
COMPLETED
Last Update Posted:
2024-04-12
First Post:
2015-07-09
Brief Title:
A Phase 1 Study of Fisogatinib BLU-554 in Patients With Hepatocellular Carcinoma
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Organization Data
Organization:
Blueprint Medicines Corporation
Class:
INDUSTRY
Study ID:
BLU-554-1101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Blueprint Medicines Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None